Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance

Gut

Volumn 43, Issue 3, 1998, Pages 317-321

  Maeda, S ^a,b   Yoshida, H ^a   Ogura, K ^a   Kanai, F ^a   Shiratori, Y ^a   Omata, M ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Clarithromycin; Eradication; Helicobacter pylori; Point mutation; Resistance

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIAL DNA; CLARITHROMYCIN; PROTON PUMP INHIBITOR; RNA 23S;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; GASTRITIS; GENE MUTATION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CANCER; STOMACH DISEASE;

EID: 0031696084     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.3.317     Document Type: Article

References (21)

1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;i:1273-5.
2. NIH consensus conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994;272:65-9.
3. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann Intern Med 1992;116:705-8.
4. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
5. Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
6. Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995;333:984-91.
7. Lind T, Veldhuyzen S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I study. Helicobacter 1996;1:138-44.
8. Chiba N. Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori. Am J Gastroenterol 1996;91:2139-43.
9. Labenz J, Stolte M, Ruhl GH, et al. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995;7:9-11.
10. Penston JG, McColl KE. Eradication of Helicobacter pylori: an objective assessment of current therapies. Br J Clin Pharmacol 1997;43:223-43.
11. Gotoh A, Kawakami Y, Akahane T, et al. Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy. Micobiol Immun 1997;41:7-12.
12. Van Zwet AA, Deboer WA, Schneeberger PM, et al. Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands. Eur J Clin Microbiol Infect Dis 1996;15:861-4.
13. Midolo PD, Lambert JR, Turnidge J. Metronidazole resistance: a predictor failure of Helicobacter pylori eradication by triple thrapy. J Gastroenterol Hepatol 1996;11: 290-2.
14. Weldon MJ, Broadbent A, Chambers S, et al. A seven-day Helicobacter pylori treatment regimen using clarithromycin, omeprazole and tripotassium dicitrato bismuthate. Aliment Pharmacol Ther 1996;10:279-83.
15. Cayla R, Zerbib F, Talbi P, et al. Pre and post-treatment clarithromycin resistance of Helicobacter pylori strains: key factor of treatment failure [abstract]. Gut 1996;37(suppl 1):A55.
16. Debets-Ossenkopp YJ, Sparrius M, Kusters JG, et al. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Lett 1996;142:37-42.
17. Versalovic J, Shortridge D, Kibler K, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996;40: 477-80.
18. Kawamata O, Yoshida H, Hirota K, et al. Nested-polymerase chain reaction for the detection of Helicobacter pylori infection with novel primers designed by sequence analysis of urease A gene in clinically isolated bacterial strains. Biochem Biophys Res Commun 1996;219:266-72.
19. Yoshida H, Hirota K, Shiratori Y, et al. Use of a gastric juice-based PCR assay to detect Helicobacter pylori infection in culture-negative patients. J Clin Microbiol 1998;36: 317-20.
20. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-7.
21. Stone GG, Shortridge D, Versalovic J, et al. PCR oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin resistant Helicobacter pylori. Antimicrob Agents Chemother 1997;41: 712-14.